References
- Winning L, Linden GJ. Periodontitis and systemic disease: association or causality? Curr Oral Health Rep 2017;4(1):1–7. doi:https://doi.org/10.1007/s40496-017-0121-7.
- Smith KA. Louis Pasteur, the father of immunology? Front Immunol 2012;3:68.
- Miller WD. The human mouth as a focus of infection. Lancet 1891;138(3546):340–342.
- Burns R. Oral foci of infection, their diagnosis, differentiation and systemic manifestations. Cal State J Med 1922;20(4):120–124.
- Zhang Y, Wang X, Li H, et al. Human oral microbiota and its modulation for oral health. Biomed Pharmacother 2018;99:883–893. doi:https://doi.org/10.1016/j.biopha.2018.01.146.
- Offenbacher S. Periodontal diseases: pathogenesis. Ann Periodontol 1996;1(1):821–878. doi:https://doi.org/10.1902/annals.1996.1.1.821.
- Sampaio-Maia B, Caldas IM, Pereira ML, et al. The oral microbiome in health and its implication in oral and systemic diseases. Adv Appl Microbiol 2016;97:171–210. doi:https://doi.org/10.1016/bs.aambs.2016.08.002.
- Pappas G, Kiriaze IJ, Falagas ME. Insights into infectious disease in the era of Hippocrates. Int J Infect Dis 2008;12(4):347–350. doi:https://doi.org/10.1016/j.ijid.2007.11.003.
- Entezami P, Fox DA, Clapham PJ, Chung KC. Historical perspective on the etiology of rheumatoid arthritis. Hand Clin 2011;27(1):1–10. doi:https://doi.org/10.1016/j.hcl.2010.09.006.
- Marsh PD. Role of the oral microflora in health. Microb Ecol Health Dis 2000;12(3):130–137.
- Lamont RJ, Koo H, Hajishengallis G. The oral microbiota: dynamic communities and host interactions. Nat Rev Microbiol 2018;16(12):745–759. doi:https://doi.org/10.1038/s41579-018-0089-x.
- Aas JA, Paster BJ, Stokes LN, et al. Defining the normal bacterial flora of the oral cavity. J Clin Microbiol 2005;43(11):5721–5732. doi:https://doi.org/10.1128/JCM.43.11.5721-5732.2005.
- Avila M, Ojcius DM, Yilmaz O. The oral microbiota: living with a permanent guest. DNA Cell Biol 2009;28(8):405–411. doi:https://doi.org/10.1089/dna.2009.0874.
- Marsh PD. Dental plaque as a biofilm and a microbial community – implications for health and disease. BMC Oral Health 2006;6(Suppl 1):S14. doi:https://doi.org/10.1186/1472-6831-6-S1-S14.
- Zheng W, Tan MF, Old LA, et al. Distinct biological potential of Streptococcus gordonii and Streptococcus sanguinis revealed by comparative genome analysis. Sci Rep 2017;7(1):2949. doi:https://doi.org/10.1038/s41598-017-02399-4.
- Rath H, Feng D, Neuweiler I, et al. Biofilm formation by the oral pioneer colonizer Streptococcus gordonii: an experimental and numerical study. FEMS Microbiol Ecol 2017;93(3). doi:https://doi.org/10.1093/femsec/fix010.
- Popova C, Dosseva-Panova V, Panov V. Microbiology of periodontal diseases. A review. Biotechnol Biotechnol Equip 2013;27(3):3754–3759.
- Demmer RT, Papapanou PN, Jacobs DR, Jr., Desvarieux M. Bleeding on probing differentially relates to bacterial profiles: the Oral Infections and Vascular Disease Epidemiology Study. J Clin Periodontol 2008;35(6):479–486.
- Topcuoglu N, Kulekci G. 16S rRNA based microarray analysis of ten periodontal bacteria in patients with different forms of periodontitis. Anaerobe 2015;35(Pt A):35–40. doi:https://doi.org/10.1016/j.anaerobe.2015.01.011.
- Michaud DS. Role of bacterial infections in pancreatic cancer. Carcinogenesis 2013;34(10):2193–2197. doi:https://doi.org/10.1093/carcin/bgt249.
- Duran-Pinedo AE, Frias-Lopez J. Beyond microbial community composition: functional activities of the oral microbiome in health and disease. Microbes Infect 2015;17(7):505–516. doi:https://doi.org/10.1016/j.micinf.2015.03.014.
- Michaud DS, Fu Z, Shi J, Chung M. Periodontal disease, tooth loss, and cancer risk. Epidemiol Rev 2017;39(1):49–58. doi:https://doi.org/10.1093/epirev/mxx006.
- Eke PI, Borgnakke WS, Genco RJ. Recent epidemiologic trends in periodontitis in the USA. Periodontol 2000 2020;82(1):257–267. doi:https://doi.org/10.1111/prd.12323.
- Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet 2005;366(9499):1809–1820.
- Socransky SS, Haffajee AD, Smith C, Dibart S. Relation of counts of microbial species to clinical status at the sampled site. J Clin Periodontol 1991;18(10):766–775. doi:https://doi.org/10.1111/j.1600-051x.1991.tb00070.x.
- Kinane DF. Periodontitis modified by systemic factors. Ann Periodontol 1999;4(1):54–64. doi:https://doi.org/10.1902/annals.1999.4.1.54.
- Hajishengallis G. Periodontitis: from microbial immune subversion to systemic inflammation. Nat Rev Immunol 2015;15(1):30–44. doi:https://doi.org/10.1038/nri3785.
- Larsen T, Fiehn NE. Dental biofilm infections – an update. APMIS 2017;125(4):376–384. doi:https://doi.org/10.1111/apm.12688.
- Bartold PM, Van Dyke TE. Periodontitis: a host-mediated disruption of microbial homeostasis. Unlearning learned concepts. Periodontol 2000 2013;62(1):203–217. doi:https://doi.org/10.1111/j.1600-0757.2012.00450.x.
- Socransky SS, Haffajee AD, Cugini MA, et al. Microbial complexes in subgingival plaque. J Clin Periodontol 1998;25(2):134–144. doi:https://doi.org/10.1111/j.1600-051x.1998.tb02419.x.
- Zambon JJ. Periodontal diseases: microbial factors. Ann Periodontol 1996;1(1):879–925. doi:https://doi.org/10.1902/annals.1996.1.1.879.
- Darveau RP, Tanner A, Page RC. The microbial challenge in periodontitis. Periodontol 2000 1997;14:12–32. doi:https://doi.org/10.1111/j.1600-0757.1997.tb00190.x.
- Hajishengallis G, Darveau RP, Curtis MA. The keystone-pathogen hypothesis. Nat Rev Microbiol 2012;10(10):717–725. doi:https://doi.org/10.1038/nrmicro2873.
- Griffen AL, Becker MR, Lyons SR, et al. Prevalence of Porphyromonas gingivalis and periodontal health status. J Clin Microbiol 1998;36(11):3239–3242.
- Lamont RJ, Jenkinson HF. Subgingival colonization by Porphyromonas gingivalis. Oral Microbiol Immunol 2000;15(6):341–349. doi:https://doi.org/10.1034/j.1399-302x.2000.150601.x.
- Pandit N, Changela R, Bali D, et al. Porphyromonas gingivalis: its virulence and vaccine. J Int Clin Dent Res Organ 2015;7(1):51–58.
- Kimura S, Nagai A, Onitsuka T, et al. Induction of experimental periodontitis in mice with Porphyromonas gingivalis-adhered ligatures. J Periodontol 2000;71(7):1167–1173.
- Takii R, Kadowaki T, Baba A, et al. A functional virulence complex composed of gingipains, adhesins, and lipopolysaccharide shows high affinity to host cells and matrix proteins and escapes recognition by host immune systems. Infect Immun 2005;73(2):883–893. doi:https://doi.org/10.1128/IAI.73.2.883-893.2005.
- Arjunan P, El-Awady A, Dannebaum RO, et al. High-throughput sequencing reveals key genes and immune homeostatic pathways activated in myeloid dendritic cells by Porphyromonas gingivalis 381 and its fimbrial mutants. Mol Oral Microbiol 2016;31(1):78–93. doi:https://doi.org/10.1111/omi.12131.
- Arjunan P, Meghil MM, Pi W, et al. Oral pathobiont activates anti-apoptotic pathway, promoting both immune suppression and oncogenic cell proliferation. Sci Rep 2018;8(1):16607. doi:https://doi.org/10.1038/s41598-018-35126-8.
- Hajishengallis G, Lambris JD. Microbial manipulation of receptor crosstalk in innate immunity. Nat Rev Immunol 2011;11(3):187–200. doi:https://doi.org/10.1038/nri2918.
- Kuboniwa M, Lamont RJ. Subgingival biofilm formation. Periodontol 2000 2010;52(1):38–52. doi:https://doi.org/10.1111/j.1600-0757.2009.00311.x.
- Kuboniwa M, Hendrickson EL, Xia Q, et al. Proteomics of Porphyromonas gingivalis within a model oral microbial community. BMC Microbiol 2009;9:98. doi:https://doi.org/10.1186/1471-2180-9-98.
- Redanz S, Standar K, Podbielski A, Kreikemeyer BA. Five-species transcriptome array for oral mixed-biofilm studies. PLoS One 2011;6(12):e27827.
- Velsko IM, Chukkapalli SS, Rivera MF, et al. Active invasion of oral and aortic tissues by Porphyromonas gingivalis in mice causally links periodontitis and atherosclerosis. PLoS One 2014;9(5):e97811.
- Chen Y, Zhou R, Yi Z, et al. Porphyromonas gingivalis induced inflammatory responses and promoted apoptosis in lung epithelial cells infected with H1N1 via the Bcl‑2/Bax/Caspase‑3 signaling pathway. Mol Med Rep 2018;18(1):97–104.
- Ding Y, Ren J, Yu H, et al. Porphyromonas gingivalis, a periodontitis causing bacterium, induces memory impairment and age-dependent neuroinflammation in mice. Immun Ageing 2018;15:6. doi:https://doi.org/10.1186/s12979-017-0110-7.
- Pritchard AB, Crean S, Olsen I, Singhrao SK. Periodontitis, microbiomes and their role in Alzheimer's disease. Front Aging Neurosci 2017;9:336. doi:https://doi.org/10.3389/fnagi.2017.00336.
- Jung H, Jung SM, Rim YA, et al. Arthritic role of Porphyromonas gingivalis in collagen-induced arthritis mice. PLoS One 2017;12(11):e0188698. doi:https://doi.org/10.1371/journal.pone.0188698.
- Miyauchi M, Ao M, Furusho H, et al. Galectin-3 plays an important role in preterm birth caused by dental infection of Porphyromonas gingivalis. Sci Rep 2018;8(1):2867. doi:https://doi.org/10.1038/s41598-018-21072-y.
- Artese HP, Foz AM, Rabelo Mde S, et al. Periodontal therapy and systemic inflammation in type 2 diabetes mellitus: a meta-analysis. PLoS One 2015;10(5):e0128344.
- Ghizoni JS, Taveira LA, Garlet GP, et al. Increased levels of Porphyromonas gingivalis are associated with ischemic and hemorrhagic cerebrovascular disease in humans: an in vivo study. J Appl Oral Sci 2012;20(1):104–112.
- MacNevin MG, Vaughan HS, Memorial JPR. Abstract of the Literature on Mouth Infections and Their Relation to Systemic Diseases. New York, NY: Joseph Purcell Research Memorial; 1922.
- Willcox MD. Characterization of the normal microbiota of the ocular surface. Exp Eye Res 2013;117:99–105.
- Shimizu E, Ogawa Y, Saijo Y, et al. Commensal microflora in human conjunctiva; characteristics of microflora in the patients with chronic ocular graft-versus-host disease. Ocul Surf 2019;17(2):265–271. doi:https://doi.org/10.1016/j.jtos.2019.02.001.
- Tlaskalová-Hogenová H, Štěpánková R, Hudcovic T, et al. Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Immunol Lett 2004;93(2–3):97–108. doi:https://doi.org/10.1016/j.imlet.2004.02.005.
- Lin P. The role of the intestinal microbiome in ocular inflammatory disease. Curr Opin Ophthalmol 2018;29(3):261–266. doi:https://doi.org/10.1097/ICU.0000000000000465.
- Sen HN, Chaigne-Delalande B, Li Z, et al. Gut microbiome in uveitis. Invest Ophthalmol Visual Sci 2017;58(8):846–846.
- Héron E, Bourcier T. [Scleritis and episcleritis]. J Fr Ophtalmol 2017;40(8):681–695. doi:https://doi.org/10.1016/j.jfo.2017.04.007.
- Guncu GN, Caglayan F. Resolution of anterior scleritis after periodontal therapy. Eur J Dent 2011;5(3):337–339.
- D’Aiuto F, Parkar M, Andreou G, et al. Periodontitis and systemic inflammation: control of the local infection is associated with a reduction in serum inflammatory markers. J Dent Res 2004;83(2):156–160.
- Mesquida M, Leszczynska A, Llorenç V, Adán A. Interleukin-6 blockade in ocular inflammatory diseases. Clin Exp Immunol 2014;176(3):301–309. doi:https://doi.org/10.1111/cei.12295.
- Page RC. The role of inflammatory mediators in the pathogenesis of periodontal disease. J Periodontal Res 1991;26(3 Pt 2):230–242. doi:https://doi.org/10.1111/j.1600-0765.1991.tb01649.x.
- Yucel-Lindberg T, Båge T. Inflammatory mediators in the pathogenesis of periodontitis. Expert Rev Mol Med 2013;15:e7. doi:https://doi.org/10.1017/erm.2013.8.
- Kingman S. Glaucoma is second leading cause of blindness globally. Bull World Health Organ 2004;82(11):887–888.
- Grzybowski A, Och M, Kanclerz P, et al. Primary open angle glaucoma and vascular risk factors: a review of population based studies from 1990 to 2019. JCM 2020;9(3):761.
- Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. JAMA 2014;311(18):1901–1911. doi:https://doi.org/10.1001/jama.2014.3192.
- Nayyar A, Gindina S, Barron A, et al. Do epigenetic changes caused by commensal microbiota contribute to development of ocular disease? A review of evidence. Hum Genom 2020;14(1):11. doi:https://doi.org/10.1186/s40246-020-00257-5.
- Abbayya K, Puthanakar NY, Naduwinmani S, Chidambar YS. Association between periodontitis and Alzheimer's disease. N Am J Med Sci 2015;7(6):241–246. doi:https://doi.org/10.4103/1947-2714.159325.
- Astafurov K, Elhawy E, Ren L, et al. Oral microbiome link to neurodegeneration in glaucoma. PLoS One 2014;9(9):e104416.
- Azam S, Jakaria M, Kim IS, et al. Regulation of toll-like receptor (TLR) signaling pathway by polyphenols in the treatment of age-linked neurodegenerative diseases: focus on TLR4 signaling. Front Immunol 2019;10:1000.
- Pasquale LR, Hyman L, Wiggs JL, et al. Prospective study of oral health and risk of primary open-angle glaucoma in men: data from the health professionals follow-up study. Ophthalmology 2016;123(11):2318–2327.
- Polla D, Astafurov K, Hawy E, et al. A pilot study to evaluate the oral microbiome and dental health in primary open-angle glaucoma. J Glaucoma 2017;26(4):320–327.
- Ohira S, Inoue T, Iwao K, et al. Factors influencing aqueous proinflammatory cytokines and growth factors in uveitic glaucoma. PLoS One 2016;11(1):e0147080. doi:https://doi.org/10.1371/journal.pone.0147080.
- Verhulst MJL, Loos BG, Gerdes VEA, Teeuw WJ. Evaluating all potential oral complications of diabetes mellitus. Front Endocrinol (Lausanne) 2019;10(56):56.
- Ohlrich EJ, Cullinan MP, Leichter JW. Diabetes, periodontitis, and the subgingival microbiota. J Oral Microbiol 2010;2(1):5818.
- Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011;94(3):311–321. doi:https://doi.org/10.1016/j.diabres.2011.10.029.
- Bascones-Martinez A, Munoz-Corcuera M, Bascones-Ilundain J. [Diabetes and periodontitis: a bidirectional relationship]. Med Clin (Barc) 2015;145(1):31–35.
- Casanova L, Hughes FJ, Preshaw PM. Diabetes and periodontal disease: a two-way relationship. Br Dent J 2014;217(8):433–437. doi:https://doi.org/10.1038/sj.bdj.2014.907.
- Noma H, Sakamoto I, Mochizuki H, et al. Relationship between periodontal disease and diabetic retinopathy. Diabetes Care 2004;27(2):615. doi:https://doi.org/10.2337/diacare.27.2.615.
- Amiri AA, Maboudi A, Bahar A, et al. Relationship between type 2 diabetic retinopathy and periodontal disease in Iranian adults. North Am J Med Sci 2014;6(3):139–144.
- Song SJ, Lee SS, Han K, Park JB. Periodontitis is associated with diabetic retinopathy in non-obese adults. Endocrine 2017;56(1):82–89.
- Graves DT, Al-Mashat H, Liu R. Evidence that diabetes mellitus aggravates periodontal diseases and modifies the response to an oral pathogen in animal models. Compend Contin Educ Dent 2004;25(7 Suppl 1):38–45.
- Alagl AS. Periodontal abscess as a possible oral clinical sign in the diagnosis of undiagnosed diabetes mellitus of elderly in a dental clinic set up – a 7-year cross-sectional study. J Investig Clin Dent 2017;8(3):e12217.
- Grant-Theule DA. Periodontal disease, diabetes, and immune response: a review of current concepts. J West Soc Periodontol Periodontal Abstr 1996;44(3):69–77.
- Nitta H, Katagiri S, Nagasawa T, et al. The number of microvascular complications is associated with an increased risk for severity of periodontitis in type 2 diabetes patients: results of a multicenter hospital-based cross-sectional study. J Diabetes Investig 2017;8(5):677–686.
- Sadzeviciene R, Paipaliene P, Zekonis G, Zilinskas J. The influence of microvascular complications caused by diabetes mellitus on the inflammatory pathology of periodontal tissues. Stomatologija 2005;7(4):121–124.
- Karande AM, Khandeparkar R, Vergeese CS. Inter-relationship between diabetes mellitus and periodontal disease based on their molecular mechanisms. J Adv Med Dent Sci Res 2017;5(1):24–32.
- Pradeep AR, Prapulla DV, Sharma A, Sujatha PB. Gingival crevicular fluid and serum vascular endothelial growth factor: their relationship in periodontal health, disease and after treatment. Cytokine 2011;54(2):200–204. doi:https://doi.org/10.1016/j.cyto.2011.02.010.
- Murata T, Nagai R, Ishibashi T, et al. The relationship between accumulation of advanced glycation end products and expression of vascular endothelial growth factor in human diabetic retinas. Diabetologia 1997;40(7):764–769.
- Veena HR, Natesh S, Patil SR. Association between diabetic retinopathy and chronic periodontitis – a cross-sectional study. Med Sci (Basel) 2018;6(4):104.
- Cani PD, Amar J, Iglesias MA, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007;56(7):1761–1772. doi:https://doi.org/10.2337/db06-1491.
- Liang H, Hussey SE, Sanchez-Avila A, et al. Effect of lipopolysaccharide on inflammation and insulin action in human muscle. PloS One 2013;8(5):e63983. doi:https://doi.org/10.1371/journal.pone.0063983.
- Bhat UG, Ilievski V, Unterman TG, Watanabe K. Porphyromonas gingivalis lipopolysaccharide upregulates insulin secretion from pancreatic beta cell line MIN6. J Periodontol 2014;85(11):1629–1636.
- Burleson GR. Immunological variation due to genetics of inflammatory SNPs and age and impact on disease manifestation. Toxicol Pathol 2017;45(1):146–149. doi:https://doi.org/10.1177/0192623316677070.
- Wang X, Bao W, Liu J, et al. Inflammatory markers and risk of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care 2013;36(1):166–175. doi:https://doi.org/10.2337/dc12-0702.
- Iacopino AM. Periodontitis and diabetes interrelationships: role of inflammation. Ann Periodontol 2001;6(1):125–137. doi:https://doi.org/10.1902/annals.2001.6.1.125.
- Wu H, Ballantyne CM. Skeletal muscle inflammation and insulin resistance in obesity. J Clin Invest 2017;127(1):43–54.
- Graves DT, Kayal RA. Diabetic complications and dysregulated innate immunity. Front Biosci 2008;13:1227–1239. doi:https://doi.org/10.2741/2757.
- Chang P-C, Lim LP. Interrelationships of periodontitis and diabetes: a review of the current literature. J Dent Sci 2012;7(3):272–282. doi:https://doi.org/10.1016/j.jds.2012.02.002.
- Roca-Millan E, Gonzalez-Navarro B, Sabater-Recolons MM, et al. Periodontal treatment on patients with cardiovascular disease: systematic review and meta-analysis. Med Oral 2018;23(6):e681–e690.
- Akcali A, Guven Yilmaz S, Lappin DF, et al. Effect of gingival inflammation on the inflammatory response in patients with idiopathic uveitis. J Clin Periodontol 2016;43(8):637–645.
- Sutedjo W, Prahasanthi C, Utomo DH. The uveitis – periodontal disease connection in pregnancy: controversy between myth and reality. Indonesian J Trop Infect Dis 2015;3(1):30–34.
- Lehner T. The role of heat shock protein, microbial and autoimmune agents in the aetiology of Behçet's disease. Int Rev Immunol 1997;14(1):21–32. doi:https://doi.org/10.3109/08830189709116842.
- Arabaci T, Kara C, Çiçek Y. Relationship between periodontal parameters and Behçet’s disease and evaluation of different treatments for oral recurrent aphthous stomatitis. J Periodont Res 2009;44(6):718–725.
- Celenligil-Nazliel H, Kansu E, Ebersole JL. Periodontal findings and systemic antibody responses to oral microorganisms in Behçet's disease. J Periodontol 1999;70(12):1449–1456.
- Coit P, Mumcu G, Ture-Ozdemir F, et al. Sequencing of 16S rRNA reveals a distinct salivary microbiome signature in Behçet's disease. Clin Immunol 2016;169:28–35. doi:https://doi.org/10.1016/j.clim.2016.06.002.
- Leccese P, Alpsoy E. Behcet's disease: an overview of etiopathogenesis. Front Immunol 2019;10:1067.
- Gül A. Behçet's disease: an update on the pathogenesis. Clin Exp Rheumatol 2001;19(5 Suppl 24):S6–S12.
- Ignat F, Bărăscu D, Mocanu C, Călăraşu C. [Inflammatory ocular diseases associated with oro-dental pathology]. Oftalmologia 2001;52(2):67–71.
- Akman A, Kacaroglu H, Donmez L, et al. Relationship between periodontal findings and Behcet's disease: a controlled study. J Clin Periodontol 2007;34(6):485–491.
- Ahn JK, Yu HG, Chung H, Park YG. Intraocular cytokine environment in active Behçet uveitis. Am J Ophthalmol 2006;142(3):429–434. doi:https://doi.org/10.1016/j.ajo.2006.04.016.
- Agrawal R, Iyer J, Connolly J, et al. Cytokines and biologics in non-infectious autoimmune uveitis: bench to bedside. Indian J Ophthalmol 2014;62(1):74–81. doi:https://doi.org/10.4103/0301-4738.126187.
- Singh P, Gupta ND, Bey A, Khan S. Salivary TNF-alpha: a potential marker of periodontal destruction. J Indian Soc Periodontol 2014;18(3):306–310. doi:https://doi.org/10.4103/0972-124X.134566.
- Arjunan P, Lin X, Tang Z, et al. VEGF-B is a potent antioxidant. Proc Natl Acad Sci USA 2018;115(41):10351–10356.
- Majumdar U, Arya G, Singh S, et al. Oro-dental findings in Bardet–Biedl syndrome. BMJ Case Rep 2012;2012: doi:https://doi.org/10.1136/bcr.12.2011.5320.
- Yalcin ED, Ararat E. Oral and dental findings in Bardet–Biedl syndrome: a case report. Niger J Clin Pract 2019;22(7):1026–1028. doi:https://doi.org/10.4103/njcp.njcp_615_18.
- Szmigielska A, Krzemień G, Roszkowska-Blaim M, Obersztyn E. Polydactyly and obesity – the clinical manifestation of ciliopathy: a boy with Bardet–Biedl syndrome. Dev Period Med 2016;20(2):105–109.
- Mays JW, Sarmadi M, Moutsopoulos NM. Oral manifestations of systemic autoimmune and inflammatory diseases: diagnosis and clinical management. J Evid Based Dent Pract 2012;12(3 Suppl):265–282.
- Olate S, Muñoz D, Neumann S, et al. A descriptive study of the oral status in subjects with Sjögren's syndrome. Int J Clin Exp Med 2014;7(4):1140–1144.
- Shiboski CH, Shiboski SC, Seror R, et al. 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome: a consensus and data-driven methodology involving three international patient cohorts . Ann Rheum Dis 2017;76(1):9–16., doi:https://doi.org/10.1136/annrheumdis-2016-210571.
- De Luca F, Shoenfeld Y. The microbiome in autoimmune diseases. Clin Exp Immunol 2019;195(1):74–85.
- Najera MP, Al-Hashimi I, Plemons JM, et al. Prevalence of periodontal disease in patients with Sjogren's syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;83(4):453–457.
- Lin C-Y, Tseng C-F, Liu J-M, et al. Association between periodontal disease and subsequent Sjögren's syndrome: a nationwide population-based cohort study. IJERPH 2019;16(5):771.
- Lin TC, Tseng CF, Wang YH, et al. Patients with chronic periodontitis present increased risk for primary Sjögren syndrome: a nationwide population-based cohort study. PeerJ 2018;6:e5109. doi:https://doi.org/10.7717/peerj.5109.
- Napenas JJ, Rouleau TS. Oral complications of Sjögren's syndrome. Oral Maxillofac Surg Clin North Am 2014;26(1):55–62. doi:https://doi.org/10.1016/j.coms.2013.09.004.
- Maarse F, Jager DHJ, Alterch S, et al. Sjogren's syndrome is not a risk factor for periodontal disease: a systematic review. Clin Exp Rheumatol 2019;37 Suppl 118(3):225–233.
- Ambrosio LM, Rovai ES, Franca BN, et al. Effects of periodontal treatment on primary Sjogren's syndrome symptoms. Braz Oral Res 2017;31:e8.
- Morita F, Hirai Y, Suzuki K, et al. Infective endocarditis and Sjögren's syndrome diagnosed simultaneously. IDCases 2017;7:6–8. doi:https://doi.org/10.1016/j.idcr.2016.11.003.
- Celenligil H, Eratalay K, Kansu E, Ebersole JL. Periodontal status and serum antibody responses to oral microorganisms in Sjogren's syndrome. J Periodontol 1998;69(5):571–577.
- Detert J, Pischon N, Burmester GR, Buttgereit F. [Pathogenesis of parodontitis in rheumatic diseases]. Z Rheumatol 2010;69(2):109–116. doi:https://doi.org/10.1007/s00393-009-0560-1.
- Trujillo-Vargas CM, Schaefer L, Alam J, et al. The gut–eye–lacrimal gland–microbiome axis in Sjögren syndrome. Ocul Surf 2020;18(2):335–344. doi:https://doi.org/10.1016/j.jtos.2019.10.006.
- Nayar G, Gauna A, Chukkapalli S, et al. Polymicrobial infection alter inflammatory microRNA in rat salivary glands during periodontal disease. Anaerobe 2016;38:70–75.
- Kwok SK, Cho ML, Her YM, et al. TLR2 ligation induces the production of IL-23/IL-17 via IL-6, STAT3 and NF-kB pathway in patients with primary Sjogren's syndrome. Arthritis Res Ther 2012;14(2):R64. doi:https://doi.org/10.1186/ar3780.
- Bunte K, Beikler T. Th17 cells and the IL-23/IL-17 axis in the pathogenesis of periodontitis and immune-mediated inflammatory diseases. IJMS 2019;20(14):3394.
- de Goés Soares L, Rocha RL, Bagordakis E, et al. Relationship between Sjögren syndrome and periodontal status: a systematic review. Oral Surg Oral Med Oral Pathol Oral Radiol 2018;125(3):223–231. doi:https://doi.org/10.1016/j.oooo.2017.11.018.
- Wong WL, Su X, Li X, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health 2014;2(2):e106–e116.
- Jonas JB, Cheung CMG, Panda-Jonas S. Updates on the epidemiology of age-related macular degeneration. Asia Pac J Ophthalmol (Phila.) 2017;6(6):493–497.
- Javed F, Sculean A, Romanos GE. Association between age-related macular degeneration and periodontal and peri-implant diseases: a systematic review. Acta Ophthalmol 2020. doi:https://doi.org/10.1111/aos.14629.
- NEI. Age-related macular degeneration (AMD) data and statistics. https://www.nei.nih.gov/learn-about-eye-health/resources-for-health-educators/eye-health-data-and-statistics/age-related-macular-degeneration-amd-data-and-statistics.
- Pennington KL, DeAngelis MM. Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors. Eye Vis (Lond) 2016;3(1):34. doi:https://doi.org/10.1186/s40662-016-0063-5.
- Rein DB, Wittenborn JS, Zhang X, et al. Forecasting age-related macular degeneration through the year 2050: the potential impact of new treatments. Arch Ophthalmol 2009;127(4):533–540. doi:https://doi.org/10.1001/archophthalmol.2009.58.
- Eke PI, Dye BA, Wei L, et al. Update on prevalence of periodontitis in adults in the United States: NHANES 2009 to 2012. J Periodontol 2015;86(5):611–622. doi:https://doi.org/10.1902/jop.2015.140520.
- Ambati J, Atkinson JP, Gelfand BD. Immunology of age-related macular degeneration. Nat Rev Immunol 2013;13(6):438–451.
- Evans JR. Risk factors for age-related macular degeneration. Prog Retin Eye Res 2001;20(2):227–253.
- Forrester JV. Macrophages eyed in macular degeneration. Nat Med 2003;9(11):1350–1351. doi:https://doi.org/10.1038/nm1103-1350.
- Hernández-Zimbrón LF, Zamora-Alvarado R, Ochoa-De la Paz L, et al. Age-related macular degeneration: new paradigms for treatment and management of AMD. Oxid Med Cell Longev 2018;2018:8374647. doi:https://doi.org/10.1155/2018/8374647.
- Dasari B, Prasanthi JRP, Marwarha G, et al. Cholesterol-enriched diet causes age-related macular degeneration-like pathology in rabbit retina. BMC Ophthalmol 2011;11(1):22. doi:https://doi.org/10.1186/1471-2415-11-22.
- Guo L, Duggan J, Cordeiro MF. Alzheimer's disease and retinal neurodegeneration. Curr Alzheimer Res 2010;7(1):3–14.
- Moschos MM, Nitoda E, Chatziralli IP, Demopoulos CA. Age-related macular degeneration: pathogenesis, genetic background, and the role of nutritional supplements. J Chem 2014;2014:1–9.
- Coleman HR, Chan C-C, Ferris FL, 3rd, Chew EY. Age-related macular degeneration. Lancet (London, England) 2008;372(9652):1835–1845.
- Ho EXP, Cheung CMG, Sim S, et al. Human pharyngeal microbiota in age-related macular degeneration. PloS One 2018;13(8):e0201768. doi:https://doi.org/10.1371/journal.pone.0201768.
- Rullo J, Far PM, Quinn M, et al. Local oral and nasal microbiome diversity in age-related macular degeneration. Sci Rep 2020;10(1):3862–3862.
- Lin P. Importance of the intestinal microbiota in ocular inflammatory diseases: a review. Clin Exp Ophthalmol 2019;47(3):418–422. doi:https://doi.org/10.1111/ceo.13493.
- Zinkernagel MS, Zysset-Burri DC, Keller I, et al. Association of the intestinal microbiome with the development of neovascular age-related macular degeneration. Sci Rep 2017;7:40826. doi:https://doi.org/10.1038/srep40826.
- Andriessen EM, Wilson AM, Mawambo G, et al. Gut microbiota influences pathological angiogenesis in obesity-driven choroidal neovascularization. EMBO Mol Med 2016;8(12):1366–1379. doi:https://doi.org/10.15252/emmm.201606531.
- Shijo T, Sakurada Y, Fukuda Y, et al. Association of CRP levels with ARMS2 and CFH variants in age-related macular degeneration. Int Ophthalmol 2020;40(10):2735–2742.
- Seddon JM, Gensler G, Rosner B. C-reactive protein and CFH, ARMS2/HTRA1 gene variants are independently associated with risk of macular degeneration. Ophthalmology 2010;117(8):1560–1566. doi:https://doi.org/10.1016/j.ophtha.2009.11.020.
- Pockpa ZAD, Struillou X, Kone D, et al. Periodontal diseases and age-related macular degeneration: is there a link? A review. Perm J 2019;23(18):260.
- Sun KT, Hsia NY, Chen SC, et al. Risk of age-related macular degeneration in patients with periodontitis: a nationwide population-based cohort study. Retina 2019. Publish Ahead of Print.
- Chiu C-J, Kantarci A, Klein R. Infection patterns of periodontal microbiota and age-related macular degeneration. Invest Ophthalmol Visual Sci 2019;60(9):1722–1722.
- Shin YU, Lim HW, Hong EH, et al. The association between periodontal disease and age-related macular degeneration in the Korea National health and nutrition examination survey: a cross-sectional observational study. Medicine (Baltimore) 2017;96(14):e6418. doi:https://doi.org/10.1097/MD.0000000000006418.
- Wagley S, Marra KV, Salhi RA, et al. Periodontal disease and age-related macular degeneration: results from the national health and nutrition examination survey III. Retina 2015;35(5):982–988. doi:https://doi.org/10.1097/IAE.0000000000000427.
- Brzozowska A, Puchalska-Niedbal L. [Oral status as a potential source of infection in AMD patients – introduction]. Klin Oczna 2012;114(1):29–32.
- Karesvuo P, Gursoy UK, Pussinen PJ, et al. Alveolar bone loss associated with age-related macular degeneration in males. J Periodontol 2013;84(1):58–67.
- Arjunan P. Investigating the enigmatic link between periodontal inflammation and retinal degeneration. 2018. https://aadr2018.zerista.com/poster/member/121775.
- Hajishengallis G. Porphyromonas gingivalis–host interactions: open war or intelligent guerilla tactics? Microbes Infect 2009;11(6–7):637–645. doi:https://doi.org/10.1016/j.micinf.2009.03.009.
- Arjunan P, Swaminathan R, Yuan J, et al. Invasion of human retinal pigment epithelial cells by Porphyromonas gingivalis leading to vacuolar/cytosolic localization and autophagy dysfunction in-vitro. Sci Rep 2020;10(1):7468. doi:https://doi.org/10.1038/s41598-020-64449-8.
- Tuo J, Grob S, Zhang K, Chan CC. Genetics of immunological and inflammatory components in age-related macular degeneration. Ocul Immunol Inflamm 2012;20(1):27–36. doi:https://doi.org/10.3109/09273948.2011.628432.
- Kauppinen A, Paterno JJ, Blasiak J, et al. Inflammation and its role in age-related macular degeneration. Cell Mol Life Sci 2016;73(9):1765–1786. doi:https://doi.org/10.1007/s00018-016-2147-8.
- Gendron R, Grenier D, Maheu-Robert L. The oral cavity as a reservoir of bacterial pathogens for focal infections. Microbes Infect 2000;2(8):897–906.
- Igari K, Kudo T, Toyofuku T, et al. Association between periodontitis and the development of systemic diseases. Oral Biol Dent 2014;2(1):4.
- Horliana AC, Chambrone L, Foz AM, et al. Dissemination of periodontal pathogens in the bloodstream after periodontal procedures: a systematic review. PLoS One 2014;9(5):e98271. doi:https://doi.org/10.1371/journal.pone.0098271.
- Brook I. The role of anaerobic bacteria in bacteremia. Anaerobe 2010;16(3):183–189. doi:https://doi.org/10.1016/j.anaerobe.2009.12.001.
- Debelian GJ, Olsen I, Tronstad L. Systemic diseases caused by oral microorganisms. Endod Dent Traumatol 1994;10(2):57–65.
- Cahill TJ, Prendergast BD. Infective endocarditis. Lancet 2016;387(10021):882–893. doi:https://doi.org/10.1016/S0140-6736(15)00067-7.
- Carrizales-Sepúlveda EF, Ordaz-Farías A, Vera-Pineda R, Flores-Ramírez R. Periodontal disease, systemic inflammation and the risk of cardiovascular disease. Heart Lung Circ 2018;27(11):1327–1334. doi:https://doi.org/10.1016/j.hlc.2018.05.102.
- Dominy SS, Lynch C, Ermini F, et al. Porphyromonas gingivalis in Alzheimer's disease brains: evidence for disease causation and treatment with small-molecule inhibitors. Sci Adv 2019;5(1):eaau3333. doi:https://doi.org/10.1126/sciadv.aau3333.
- Wijarnpreecha K, Yuklyaeva N, Sornprom S, Hyman C. Fusobacterium nucleatum: atypical organism of pyogenic liver abscess might be related to sigmoid diverticulitis. N Am J Med Sci 2016;8(4):197–199. doi:https://doi.org/10.4103/1947-2714.179961.
- Swidsinski A, Dörffel Y, Loening-Baucke V, et al. Acute appendicitis is characterised by local invasion with Fusobacterium nucleatum/necrophorum. Gut 2011;60(1):34–40.
- Brennan CA, Garrett WS. Fusobacterium nucleatum – symbiont, opportunist and oncobacterium. Nat Rev Microbiol 2019;17(3):156–166. doi:https://doi.org/10.1038/s41579-018-0129-6.
- Konkel JE, O'Boyle C, Krishnan S. Distal consequences of oral inflammation. Front Immunol 2019;10(1403):1403. doi:https://doi.org/10.3389/fimmu.2019.01403.
- Singhrao SK, Olsen I. Are Porphyromonas gingivalis outer membrane vesicles microbullets for sporadic Alzheimer's disease manifestation? J Alzheimers Dis Rep 2018;2(1):219–228. doi:https://doi.org/10.3233/ADR-180080.
- Page RC. The pathobiology of periodontal diseases may affect systemic diseases: inversion of a paradigm. Ann Periodontol 1998;3(1):108–120. doi:https://doi.org/10.1902/annals.1998.3.1.108.
- Rosenow EC. Studies on elective localization focal infection with special reference to oral sepsis. J Dent Res 1919;1(3):205–267.
- Somma F, Castagnola R, Bollino D, Marigo L. Oral inflammatory process and general health. Part 2: how does the periapical inflammatory process compromise general health? Eur Rev Med Pharmacol Sci 2011;15(1):35–51.
- Li X, Kolltveit KM, Tronstad L, Olsen I. Systemic diseases caused by oral infection. Clin Microbiol Rev 2000;13(4):547–558.
- Ramsey DT, Marretta SM, Hamor RE, et al. Ophthalmic manifestations and complications of dental disease in dogs and cats. J Am Anim Hosp Assoc 1996;32(3):215–224. doi:https://doi.org/10.5326/15473317-32-3-215.
- Forrester JV, Xu H, Kuffová L, et al. Dendritic cell physiology and function in the eye. Immunol Rev 2010;234(1):282–304. doi:https://doi.org/10.1111/j.0105-2896.2009.00873.x.
- Streilein JW. Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat Rev Immunol 2003;3(11):879–889. doi:https://doi.org/10.1038/nri1224.
- London A, Benhar I, Schwartz M. The retina as a window to the brain – from eye research to CNS disorders. Nat Rev Neurol 2013;9(1):44–53. doi:https://doi.org/10.1038/nrneurol.2012.227.
- Heuss ND, Lehmann U, Norbury CC, et al. Local activation of dendritic cells alters the pathogenesis of autoimmune disease in the retina. J Immunol 2012;188(3):1191–1200. doi:https://doi.org/10.4049/jimmunol.1101621.
- Kozarov E. Bacterial invasion of vascular cell types: vascular infectology and atherogenesis. Future Cardiol 2012;8(1):123–138. doi:https://doi.org/10.2217/fca.11.75.
- Carrion J, Scisci E, Miles B, et al. Microbial carriage state of peripheral blood dendritic cells (DCs) in chronic periodontitis influences DC differentiation, atherogenic potential. J Immunol 2012;189(6):3178–3187.
- Pournaras CJ, Rungger-Brändle E, Riva CE, et al. Regulation of retinal blood flow in health and disease. Prog Retin Eye Res 2008;27(3):284–330. doi:https://doi.org/10.1016/j.preteyeres.2008.02.002.
- Devine L, Lightman SL, Greenwood J. Role of LFA-1, ICAM-1, VLA-4 and VCAM-1 in lymphocyte migration across retinal pigment epithelial monolayers in vitro. Immunology 1996;88(3):456–462. doi:https://doi.org/10.1046/j.1365-2567.1996.d01-666.x.
- Inana G, Murat C, An W, et al. RPE phagocytic function declines in age-related macular degeneration and is rescued by human umbilical tissue derived cells. J Transl Med 2018;16(1):63. doi:https://doi.org/10.1186/s12967-018-1434-6.
- Cutler CW, Jotwani R, Palucka KA, et al. Evidence and a novel hypothesis for the role of dendritic cells and Porphyromonas gingivalis in adult periodontitis. J Periodontal Res 1999;34(7):406–412. doi:https://doi.org/10.1111/j.1600-0765.1999.tb02274.x.
- Jotwani R, Cutler CW. Fimbriated Porphyromonas gingivalis is more efficient than fimbria-deficient P. gingivalis in entering human dendritic cells in vitro and induces an inflammatory Th1 effector response. Infect Immun 2004;72(3):1725–1732. doi:https://doi.org/10.1128/iai.72.3.1725-1732.2004.
- Hughes C, Nichols T, Pike M, et al. Cerebral venous sinus thrombosis as a presentation of COVID-19. Eur J Case Rep Intern Med 2020;7(5):001691. doi:https://doi.org/10.12890/2020_001691.
- Arjunan P. Route of COVID-19 ocular transmission and its impact. EC Ophthalmol 2020;11(5):69–72.